Mutations of TMEM106B have been identified as genetic risk factors for neurodegenerative diseases including Frontotemporal lobar degeneration (FTLD) [1] and limbic-predominant age-related TAR DNA binding protein 43 (TDP-43) encephalopathy [2]. Here, TMEM106B is linked to frontotemporal dementia.